750 results on '"Sorensen, Poul H."'
Search Results
2. A ketogenic diet rich in fish oil is superior to other fats in preventing NNK-induced lung cancer in A/J mice
3. Engineered CD47 protects T cells for enhanced antitumour immunity
4. The eEF2 kinase coordinates the DNA damage response to cisplatin by supporting p53 activation
5. Early rhombic lip Protogenin+ve stem cells in a human-specific neurovascular niche initiate and maintain group 3 medulloblastoma
6. Oncogenic ETS fusions promote DNA damage and proinflammatory responses via pericentromeric RNAs in extracellular vesicles
7. Anti-GD2 synergizes with CD47 blockade to mediate tumor eradication
8. Transcriptional immunogenomic analysis reveals distinct immunological clusters in paediatric nervous system tumours
9. Preclinical development of a chimeric antigen receptor T cell therapy targeting FGFR4 in rhabdomyosarcoma
10. Failure of human rhombic lip differentiation underlies medulloblastoma formation
11. MondoA drives malignancy in B-ALL through enhanced adaptation to metabolic stress
12. De novo and cell line models of human mammary cell transformation reveal an essential role for Yb-1 in multiple stages of human breast cancer
13. Author Correction: The VAR2CSA malaria protein efficiently retrieves circulating tumor cells in an EpCAM-independent manner
14. Optineurin links Hace1-dependent Rac ubiquitylation to integrin-mediated mechanotransduction to control bacterial invasion and cell division
15. Internalization and trafficking of CSPG-bound recombinant VAR2CSA lectins in cancer cells
16. Abstract IA019: Identification of metabolic adaptation mechanisms that confer resistance to glutathione depletion in Ewing sarcoma
17. IMMUNOTAR - Integrative prioritization of cell surface targets for cancer immunotherapy
18. Preclinical development of a chimeric antigen receptor T cell therapy targeting FGFR4 in rhabdomyosarcoma
19. Author Correction: Locoregional delivery of CAR T cells to the cerebrospinal fluid for treatment of metastatic medulloblastoma and ependymoma
20. Eukaryotic Elongation Factor 2 Kinase EFK-1/eEF2K promotes starvation resistance by preventing oxidative damage inC. elegans
21. Supplementary Figure S14 from Surface and Global Proteome Analyses Identify ENPP1 and Other Surface Proteins as Actionable Immunotherapeutic Targets in Ewing Sarcoma
22. Data from Surface and Global Proteome Analyses Identify ENPP1 and Other Surface Proteins as Actionable Immunotherapeutic Targets in Ewing Sarcoma
23. Supplementary Data S3 from Surface and Global Proteome Analyses Identify ENPP1 and Other Surface Proteins as Actionable Immunotherapeutic Targets in Ewing Sarcoma
24. Supplementary Table S1 from Surface and Global Proteome Analyses Identify ENPP1 and Other Surface Proteins as Actionable Immunotherapeutic Targets in Ewing Sarcoma
25. Abstract IA16: Creation and preliminary analyses of a full spectrum of breast cancers initiated de novo from normal human mammary cells
26. Actions speak louder than ORFs: A non-canonical microprotein promotes medulloblastoma oncogenesis
27. HACE1 blocks HIF1α accumulation under hypoxia in a RAC1 dependent manner
28. Current state of pediatric sarcoma biology and opportunities for future discovery: A report from the sarcoma translational research workshop
29. Cystine/glutamate antiporter xCT (SLC7A11) facilitates oncogenic RAS transformation by preserving intracellular redox balance
30. Locoregionally administered B7-H3-targeted CAR T cells for treatment of atypical teratoid/rhabdoid tumors
31. Author Correction: Failure of human rhombic lip differentiation underlies medulloblastoma formation
32. Methods for Identifying Patients with Tropomyosin Receptor Kinase (TRK) Fusion Cancer
33. Locoregional delivery of CAR T cells to the cerebrospinal fluid for treatment of metastatic medulloblastoma and ependymoma
34. α-Synuclein pathology in Parkinson disease activates homeostatic NRF2 anti-oxidant response
35. A proteogenomic surfaceome study identifies DLK1 as an immunotherapeutic target in neuroblastoma
36. A proteogenomic surfaceome study identifies DLK1 as an immunotherapeutic target in neuroblastoma
37. Surface and Global Proteome Analyses Identify ENPP1 and Other Surface Proteins as Actionable Immunotherapeutic Targets in Ewing Sarcoma
38. The HACE1 E3 ligase mediates RAC1‐dependent control of mTOR signaling complexes
39. Androgen receptor (AR) antagonism triggers acute succinate‐mediated adaptive responses to reactivate AR signaling
40. Translational control in brain pathologies: biological significance and therapeutic opportunities
41. Single-pot, solid-phase-enhanced sample preparation for proteomics experiments
42. Supplementary Material and Methods S1 from A Bifunctional PARP-HDAC Inhibitor with Activity in Ewing Sarcoma
43. Supplementary Figure S5 from A Bifunctional PARP-HDAC Inhibitor with Activity in Ewing Sarcoma
44. Data from A Bifunctional PARP-HDAC Inhibitor with Activity in Ewing Sarcoma
45. Supplementary Table S1 from A Bifunctional PARP-HDAC Inhibitor with Activity in Ewing Sarcoma
46. A MYCN-independent mechanism mediating secretome reprogramming and metastasis in MYCN -amplified neuroblastoma
47. RNA modifications in brain tumorigenesis
48. A Standardized and Reproducible Proteomics Protocol for Bottom-Up Quantitative Analysis of Protein Samples Using SP3 and Mass Spectrometry
49. A homing system targets therapeutic T cells to brain cancer
50. Novel identification of STAT1 as a crucial mediator of ETV6-NTRK3-induced tumorigenesis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.